Additionally, expected improvements in biochemical markers—such as enhanced insulin sensitivity, improved lipid profiles, and reduced systemic inflammation—will support the formulation of targeted exercise strategies to lower the risk of chronic diseases, including cardiovascular disease and type 2 diabetes. The gene discussed is INS; the disease is type 2 diabetes mellitus.